IMPLANET SA EO 001
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fix… Read more
Market Cap & Net Worth: IMPLANET SA EO 001 (IM11)
IMPLANET SA EO 001 (F:IM11) has a market capitalization of $31.74 Million (€30.92 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #30077 globally and #3327 in its home market, demonstrating a 0.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IMPLANET SA EO 001's stock price €0.22 by its total outstanding shares 143818971 (143.82 Million).
IMPLANET SA EO 001 Market Cap History: 2015 to 2026
IMPLANET SA EO 001's market capitalization history from 2015 to 2026. Data shows change from $13.33 Billion to $31.74 Million (-44.21% CAGR).
IMPLANET SA EO 001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IMPLANET SA EO 001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IM11 by Market Capitalization
Companies near IMPLANET SA EO 001 in the global market cap rankings as of March 19, 2026.
Key companies related to IMPLANET SA EO 001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
IMPLANET SA EO 001 Historical Marketcap From 2015 to 2026
Between 2015 and today, IMPLANET SA EO 001's market cap moved from $13.33 Billion to $ 31.74 Million, with a yearly change of -44.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €31.74 Million | +11.40% |
| 2025 | €28.49 Million | +89.22% |
| 2024 | €15.06 Million | +91.37% |
| 2023 | €7.87 Million | -57.97% |
| 2022 | €18.72 Million | -43.39% |
| 2021 | €33.07 Million | -81.79% |
| 2020 | €181.58 Million | -21.15% |
| 2019 | €230.30 Million | -68.80% |
| 2018 | €738.13 Million | -65.28% |
| 2017 | €2.13 Billion | -54.31% |
| 2016 | €4.65 Billion | -65.10% |
| 2015 | €13.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of IMPLANET SA EO 001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.74 Million USD |
| MoneyControl | $31.74 Million USD |
| MarketWatch | $31.74 Million USD |
| marketcap.company | $31.74 Million USD |
| Reuters | $31.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.